<html><body><h2>Case: 1273757</h2><h3> CDS Time: 1964-11-11</h3>
<patient name=1273757>
64.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">64</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">85</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Glucose</td><td width="200">120</td><td width="200">1962-10-11</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">97</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Chloride</td><td width="200">103.0</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">40</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">83</td><td width="200">1964-11-10</td></tr>
<tr><td width="200">Weight</td><td width="200">154</td><td width="200">1964-11-10</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1962-10-11</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">128</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">163</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">SGOT</td><td width="200">17</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">149</td><td width="200">1964-11-10</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Height</td><td width="200">67</td><td width="200">1964-11-10</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">163</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">BUN</td><td width="200">11</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">HCT</td><td width="200">42</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">HGB</td><td width="200">15</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Sodium</td><td width="200">137</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Creatinine</td><td width="200">0.8</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1962-10-11</td></tr>
<tr><td width="200">Pulse</td><td width="200">83</td><td width="200">1964-11-10</td></tr>
<tr><td width="200">PLT</td><td width="200">210</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">WBC</td><td width="200">6</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">SGPT</td><td width="200">23</td><td width="200">1964-11-11</td></tr>
<tr><td width="200">Tobacco_Use</td><td width="200"></td><td width="200">1964-11-10</td></tr>
<tr><td width="200">tobacco use</td><td width="200"></td><td width="200">1964-11-10</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1964-11-10</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1964-11-10</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1964-11-10</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Occulusion of cerebral arteries</td><td width="200"></td><td width="200">1964-1-11</td></tr>
<tr><td width="200">smoking</td><td width="200"></td><td width="200">1964-11-10</td></tr>
</table>
<p><b>Medications:</b> triamterene(50.0) aspirin(0.0) simvastatin(40.0) lisinopril(10.0) hydrochlorothiazide(12.5) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[Treatment_Systolic_BP(149/null) && Treatment_Diastolic_BP(83/null)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of cerebral vascular dx]()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension K >=3.5</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && Potassium(3.6/1964-11-11)]()</td></tr>
<tr><td width="200">ISH on HCTZ and BP not controlled</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && presence of HCTZ && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(149/null)]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(64.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of lipid disorder ICD9]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[presence of diagnosis of hypertension && absence of myocardial infarction && absence of diabetes mellitus && absence of heart failure && CKD by eGFR or ICD9 codes]()</td></tr>
<tr><td width="200">Hypertensive_Without_Comorbidities_That_Indicate_Non_Diuretics</td>
<td width="200"></td>
<td width="200"> Hypertension[presence of diagnosis of hypertension && absence of myocardial infarction && absence of diabetes mellitus && absence of heart failure && CKD by eGFR or ICD9 codes]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">HTN without comorbidities and K >=3.5</td>
<td width="200"></td>
<td width="200"> HTN without comorbidities and K >=3.5[presence of HTN without comorbidities && Potassium(3.6/1964-11-11)]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">High Risk for HF and DM, HTN, or atherosclerotic vascular disease</td>
<td width="200"></td>
<td width="200"> High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1964-01-11</td>
<td width="200"> Occulusion of cerebral arteries()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1964-11-10</td>
<td width="200"> Hypertension()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> HTN without comorbidities and K >=3.5[presence of HTN without comorbidities && Potassium(3.6/1964-11-11)]()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1964-11-10</td>
<td width="200"> Tobacco_Use()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1964-11-10</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> HTN without comorbidities and K >=3.5[presence of HTN without comorbidities && Potassium(3.6/1964-11-11)]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1964-11-10</td>
<td width="200"> tobacco use()
<tr> <td width="200"></td>
<td width="200">1964-11-10</td>
<td width="200"> smoking()
<tr> <td width="200"></td>
<td width="200">1964-11-10</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage A HF
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Systolic_BP(149/null))
<p>
<b>Goal:</b> LDL< 130 mg/dL(2+ Risk Factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(97.0/1964-11-11))
<p><b>Messages by Types</b>
<ul>
<li><b>Class I</b>
<ul>
<li>In patients at high risk for developing HF, systolic and diastolic hypertension should be controlled in accordance with contemporary
guidelines. (Level of Evidence: A)
<li>Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li>Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
</ul>
<li><b>Class III</b>
<ul>
<li>Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage A messages</b><br>
<ul>
<li><b>Hypertension control <font color=FF0000>preferred</font></b>(rule in criterion<i> BP not under control</i> evaluate to <b> true</b> because <i>BP not under controlTreatment_Systolic_BP(149/null)</i>)])
In patients at high risk for developing HF, systolic and diastolic hypertension should be controlled in accordance with contemporary
guidelines. (Level of Evidence: A)
<li><b>behavior control <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li><b>Periodic evaluation <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li><b>not use nutritional supplements <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
<li><b> </b><br>
<ul>
<li><b>stage A drug choices <font color=FF0000>preferred</font></b>(strict rule-in condition<i> DM or HTN or atherosclerotic vascular disease</i> evaluate to <b> true</b> because <i>Presence of hypertension</i>)])

</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>ARB<ul><li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]) <li>preference: preferred</ul><li>Ace_Inhibitor(Captopril, Lisinopril, Enalapril)<ul><li>Already being used<li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]) <li>preference: ruled out</ul></ul></body></html>